Wall Street analysts have been busy adjusting their outlooks on several key companies, resulting in a mix of upgrades and downgrades. Here’s a rundown of the notable changes and their impact on the respective stocks:
C3.ai (AI):
Piper Sandler cut the price target from $29 to $24, maintaining a Neutral rating. C3.ai shares dipped 1.9% to close at $23.01 on Wednesday.
Collegium Pharmaceutical (COLL):
HC Wainwright & Co. raised the price target from $47 to $50, reiterating a Buy rating. Collegium Pharmaceutical shares gained 2.2% to close at $38.24 on Wednesday.
ChargePoint Holdings (CHPT):
Needham lowered the price target from $3 to $2 while maintaining a Buy rating. ChargePoint shares slipped 0.6% to close at $1.69 on Wednesday.
S&P Global (SPGI):
Morgan Stanley raised the price target from $530 to $564, maintaining an Overweight rating. S&P Global shares rose 0.5% to close at $513.31 on Wednesday.
Dollar Tree (DLTR):
BMO Capital cut the price target from $130 to $68 and downgraded the stock from Outperform to Market Perform. Dollar Tree shares plummeted 22.2% to close at $63.56 on Wednesday.
Novartis (NVS):
Goldman Sachs raised the price target from $119 to $121 but downgraded the stock from Buy to Neutral. Novartis shares rose 0.7% to close at $119.38 on Wednesday.
Core & Main (CNM):
Baird cut the price target from $62 to $53, maintaining an Outperform rating. Core & Main shares fell 15.8% to close at $39.40 on Wednesday.
EVERTEC (EVTC):
Susquehanna slashed the price target from $38 to $28 and downgraded the stock from Neutral to Negative. EVERTEC shares rose 0.3% to close at $33.73 on Wednesday.
Celanese Corporation (CE):
Piper Sandler cut the price target from $180 to $150 and downgraded the stock from Overweight to Neutral. Celanese shares fell 0.8% to close at $124.31 on Wednesday.
StoneCo Ltd. (STNE):
Morgan Stanley lowered the price target from $16.5 to $7 and downgraded the stock from Equal-Weight to Underweight. StoneCo shares fell 3.8% to close at $12.61 on Wednesday.
Post Views: 5
